Profitability
Weight: 25%
A-
83
- 5yr Avg ROIC 13.9%
- Operating Margin Trend +2.66 pp/yr
UTHR
United Therapeutics Corporation
AlphaQuality composite grade, weighted for platform & compounding fcf businesses.
Capital Efficiency
Weight: 15%
B-
69
- 5yr Avg ROE 13.3%
- 5yr Share-Count CAGR 0.3%
Growth Quality
Weight: 25%
A+
98
- 5yr Revenue CAGR 17.2%
- 5yr EPS CAGR 29.0%
- Revenue-Growth Years (5) 5/5
Cash Generation
Weight: 20%
A+
94
- 5yr FCF Margin 33.0%
- 5yr FCF/NI Conversion 0.87x
Balance Sheet
Weight: 10%
A+
100
- Net Debt / EBITDA -0.86x
- Interest Coverage (EBIT/Int) 88.89x
- Altman Z-Score 21.21
Stability
Weight: 5%
B-
65
- EPS Volatility (σ/μ) 0.39
- Piotroski F-Score 6
- Negative-Revenue Years (5) 0/5
Guru Flow
Curated superinvestor sentiment — not part of the AlphaQuality grade.4 of 4 gurus held; 3 added; 1 trimmed.
- Holders
- 4
- Avg Δ position
- +386.2%
- New buys
- 0
- Full exits
- 0